 |
市场调查报告书
商品编码
1244250
电子产品的全球市场:规模，占有率，成长分析，各产品，各终端用户，各类型，产业预测(2022年～2028年)Global Electroceuticals Market Size, Share, Growth Analysis, By Product(Defibrillators, Pacemaker), By End-User(Hospitals & Clinics, Homecare & Others), By Type(Implantable Electroceutical, Non-Invasive Electroceutical) - Industry Forecast 2022-2028 |
||||||
全球电子产品的市场规模，2021年是168亿美金。该市场，预计在预测期间(2022年～2028年)以5.0％的年复合成长率扩大，2028年达到236亿4,000万美元。
本报告提供全球电子产品市场相关调查，市场概要，以及各产品，各终端用户，各类型，各地区的趋势，及加入此市场的主要企业简介等资讯。
目录
摘要整理
市场概要
亲市场分析
市场规模
- 市场动态
- 促进因素
- 机会
- 阻碍因素
- 课题
- SWOT分析
主要的市场洞察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- IP分析
- 趋势分析
- Start-Ups分析
- 原料分析
- 革新矩阵
- 开发中产品分析
- 宏观经济指标
市场动态
- 市场动态
- 促进因素
- 机会
- 阻碍因素
- 课题
- 法规情形
- SWOT分析
- 波特五力分析
全球电子产品市场，各产品
- 市场概要
- 心臟去颤器
- 心律调节器
- 深层脑部刺激器
- 脊髓刺激设备
- 迷走神经刺激设备
- 助听器
- 人工电子耳
- 其他
全球电子产品市场，各终端用户
- 市场概要
- 医院、诊疗所
- 居家照护、其他
全球电子产品市场，各类型
- 市场概要
- 植入式电子产品
- 非侵入性电子产品
- 全球电子产品市场规模，各地区
- 市场概要
- 北美
- 欧洲
- 亚太地区
- 南美
- 中东、非洲
竞争情形
- 主要企业简介
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories, Inc.
- LivaNova PLC
- MicroPort Scientific Corporation
- Sonova Group
- Nevro Corp.
- NeuroPace, Inc.
- BIOTRONIK
- Medico S.p.A.
- Nurotron Biotechnology Co. Ltd.
- MED-EL
- Aleva Neurotherapeutics SA
- NeuroSigma, Inc. (US)
- Bioinduction Ltd. (UK)
- GiMer Medical (Taiwan)
- BioControl Medical (Israel)
- tVNS Technologies GmbH (Germany)
The Global Electroceuticals Market was valued at USD 16.80 Billion in 2021, and it is expected to reach a value of USD 23.64 Billion by 2028, at a CAGR of 5.0% over the forecast period (2022 - 2028).
Medical technology has advanced quickly over the last few years, changing treatments and medicine. The market for electroceuticals has expanded tremendously as a result. The market for electroceuticals is expected to grow quickly during the projected period as a result of the healthcare industry's expansion and the widespread use of technology in medical applications.
The ageing of the population, the high prevalence of chronic diseases, the rapid improvements in medical technology, and the growing acceptance of alternative medicine are all expected to have a positive effect on market growth during the next four years. Because less invasive procedures are becoming more popular, it is predicted that demand for non-invasive electroceutical devices will surpass that for implantable electroceutical devices. However, it is projected that during the projection period the key difficulties that could restrict the potential of the electroceuticals market would be stringent regulatory standards, frequent product recalls, protracted approval procedures, and expensive costs.
During the course of the anticipated period, it is anticipated that the increasing prevalence of cardiovascular diseases will fuel market expansion for electroceuticals. In the upcoming years, it is anticipated that more cardiovascular diseases will be treated with electroceuticals. Implantable cardioverter defibrillators are expected to be in high demand during the projected period.
The recent decades have seen an upsurge in the prevalence of infectious and chronic diseases worldwide. As a result, both the demand for novel cures and the necessity for more research and development in the healthcare field have risen. The market potential for electroceuticals is expected to increase over the next four years as governments launch initiatives and provide funding to advance research and development.
Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Electroceuticals Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
Global Electroceuticals Market is segmented based on Product, End-User, type and region. Based on the product, the Global Electroceuticals Market is segmented into Defibrillators and Pacemaker, Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Hearing Aids and Cochlear Implants, and Others. Based on the end-user, the Global Electroceuticals Market is segmented into Hospitals & Clinics and Homecare & Others. By type, it is segmented into Implantable Electroceutical, Non-Invasive Electroceutical. Based on the region, the Global Electroceuticals Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Driver
The increased incidence of cardiovascular diseases is one of the main factors boosting the worldwide electroceuticals market. It is believed that cardiovascular diseases are one of the main causes of death worldwide. More than 17.3 million people die from cardiovascular disease each year, according to the World Health Organization. Additionally, 23.6 million fatalities worldwide are anticipated to result from cardiovascular diseases by 2030. 31% of people worldwide suffer from cardiovascular diseases, and low- and middle-income countries account for 80% of all fatalities. Around 800,000 Americans died in the United States from cardiovascular disease, according to the American Heart Society. This opens up a lot of potential for the global electroceuticals market to expand during the forecast period. Moreover, substantial product releases by the leading market players are thought to be another important factor that will fuel the expansion of the worldwide electroceuticals market in the years to come.
Restraint
One of the main challenges the industry faces is a lack of public awareness regarding the usage of electroceutical devices in low- and middle-income nations. The use of implantable heart rhythm management systems and other electroceutical devices is common in high-income economies. Access is restricted in low- and middle-income (LMIC) nations. According to an American Heart Association study, Latin Americans residing in the US were less knowledgeable about AEDs and how to use them. The use of a defibrillator can significantly increase the chance of survival following cardiac arrest, yet because of a lack of public knowledge, a patient may go without care.
Market Trends
There are several market participants in the worldwide electroceuticals industry. The market's major manufacturers provide a wide range of electroceuticals for the treatment of illnesses. The prominent players functioning in the global electroceutical market include Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (the US), LivaNova PLC (UK), Cochlear Ltd. (Australia), MicroPort Scientific Corporation (China), Sonova Group (Switzerland), Nevro Corp. (US), BIOTRONIK (Germany), NeuroSigma, Inc. (the US), BioControl Medical (Israel), and tVNS Technologies GmbH (Germany) among many others.
Throughout the projected period, these companies will continue to fuel market expansion by implementing a variety of growth strategies, including product launches, mergers and acquisitions, joint ventures, and technological breakthroughs and developments. In March 2021, Medtronic plc (Ireland) got US FDA approval for its Intellis Platform with Differential Target Multiplexed (DTM) programming to treat chronic intractable back and leg pain, among other recent operations by the business in the electroceutical sector. While the Vercise Genus Deep Brain Stimulation System from Boston Scientific Company (US) was given US FDA certification in January 2021.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Electroceuticals Market by Product
- Market Overview
- Defibrillators
- Pacemaker
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagus Nerve Stimulators
- Hearing Aids
- Cochlear Implants
- Others
- Global Electroceuticals Market by End-User
- Market Overview
- Hospitals & Clinics
- Homecare & Others
Global Electroceuticals Market by Type
- Market Overview
- Implantable Electroceutical
- Non-Invasive Electroceutical
- Global Electroceuticals Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cochlear Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sonova Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nurotron Biotechnology Co. Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MED-EL (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroSigma, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioinduction Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GiMer Medical (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioControl Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- tVNS Technologies GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
